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Video abstract

Abstract: Community pharmacy-based provision of immunizations in the USA has become
commonplace in the last few decades, with success in increasing rates of immunizations.
Community pharmacy-based vaccination services are provided by pharmacists educated in the
practice of immunization delivery and provide a convenient and accessible option for receiving
immunizations. The pharmacist’s role in immunization practice has been described as serving in
the roles of educator, facilitator, and immunizer. With a majority of pharmacist-provided vaccinations occurring in the community pharmacy setting, there are many examples of community
pharmacists serving in these immunization roles with successful outcomes. Different community
pharmacies employ a number of different models and workflow practices that usually consist
of a year-round in-house service staffed by their own immunizing pharmacist. Challenges that
currently exist in this setting are variability in scopes of immunization practice for pharmacists
across states, inconsistent reimbursement mechanisms, and barriers in technology. Many of
these challenges can be alleviated by continual education; working with legislators, state boards
of pharmacy, stakeholders, and payers to standardize laws; and reimbursement design. Other
challenges that may need to be addressed are improvements in communication and continuity
of care between community pharmacists and the patient centered medical home.
Keywords: immunization, pharmacy practice, pharmacists, continuity of care
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An estimated 40,000 to 50,000 adults die annually from vaccine-preventable disease in
the USA.1 Treating these patients who go without routine and recommended vaccinations
costs the health care system US$10 billion each year.2 Adult vaccination rates for routine
recommended vaccines in the USA are low, and well below projected Healthy People
2020 targets.3,4 An example of this is the annual influenza vaccination, which is recommended for all people $6 months of age. The most recent Centers for Disease Control
and Prevention (CDC) data, from the 2012–2013 influenza season, revealed an influenza
immunization rate of 45% in all people 6 months of age and older. There is also drastic
variability in coverage among different age groups. In adults 18 years and older, the influenza vaccination rate increased with increasing age – from 31.1% in those 18–49 years of
age to 66.2% in those $65 years of age.5 Looking at other vaccines, the pneumococcal
polysaccharide vaccination rate for high-risk patients aged 19–64 years of age was 20%.3
The Advisory Committee on Immunization Practices recommends a single dose of zoster
vaccine for all adults aged 60 years and older, whether or not they report a prior episode
of herpes zoster.6 However, overall, the shingles vaccination rate is only 20.1%.3 These
are just a few examples of the low immunization rates seen today in the USA.
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The underutilization of these widely available vaccines
has created an opportunity for pharmacists to play a role in
improving immunization rates and thus advancing public
health. Community pharmacy-based vaccination services
have increased the number of immunization providers and the
number of sites where patients can receive immunizations.
It is thus important to understand the current role of community pharmacy-based immunization programs in the USA
to identify opportunities and challenges for improving the
public-health infrastructure to deliver vaccinations.

Objectives
This review explores the roles of the pharmacist as educator,
facilitator, and immunizer in community pharmacy-based
vaccination services. The review also touches on the journey
to pharmacist as providers of vaccinations, delivery models,
barriers, and future directions in the area of pharmacy-based
vaccination services.

Pharmacists as providers
of vaccinations
With 93% of Americans living within 5 miles of a community pharmacy, community pharmacists are one of the most
readily accessible health care professionals in America.7 In
2011–2012, 20.1% of US adults received their influenza
vaccinations from a supermarket or drug store – an increase
from 18.4% during the 2010–2011 season.8,9 With multiple
locations in metropolitan and urban areas, extended hours,
reduced cost to administer vaccines,10 and convenience, community pharmacies address many factors that can increase
immunization rates.11,12 According to the US Bureau of
Labor Statistics, there were 286,400 pharmacist jobs in
2012.13 An estimated 51% of these pharmacists work in the
39,000 chain and 23,117 independent community pharmacy
locations across the USA.7,14 Patients often report that their
preference for receiving vaccinations in a pharmacy or
from a non-physician in a nontraditional setting is due to
convenience.15–17 Most immunizing community pharmacies provide vaccinations without an appointment, require
almost no waiting, and do not charge visit fees. Community
pharmacy hours of operation also provide extended access
outside of traditional settings, such as a physician’s office,
which has limited hours after 5 pm and is usually closed on
the weekends and holidays. When immunizations are offered
through community pharmacies during these “off-hours”,
large numbers of patients take advantage of the increased
access and convenience, especially those younger, healthier
adults in whom rates of immunizations tend to be lower.18
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In addition to capturing the younger, healthier population,
community pharmacies have been able to reach medically
underserved and difficult-to-reach populations.11,19 Community pharmacies offering vaccinations serve to complement
the health care system to increase the number of providers
and settings from which patients can receive vaccines.
As the pharmacy profession continues to move away
from strictly product distribution to direct patient care, so
does the education and training of pharmacists. Since 2000,
the doctor of pharmacy (Pharm D) degree has been the sole
degree offered to pharmacy graduates in the USA. All professional programs that graduate students with the Pharm
D undergo accreditation by the Accreditation Council for
Pharmacy Education (ACPE), which has set standards for
professional competencies and outcome expectations of
Pharm D graduates. In the 2006 Accreditation Standards
and Guidelines for the Professional Program in Pharmacy
Leading to the Doctor of Pharmacy Degree (hereafter, “ACPE
Standards”), standard number 12 notes that the professional
pharmacist competencies that must be achieved by graduates
through the Pharm D curriculum are the ability to: provide
patient-centered care; provide population-based care; manage
human, physical, medical, information, and technological
resources; manage medication-use systems; and promote
the availability of effective health and disease-prevention
services and health policy.20 It is the emphasis on providing
population-based care and disease-prevention services that
has prepared pharmacists to provide public-health services,
which would include efforts to increase immunization rates,
reach at-risk populations, and decrease the incidences and
mortality of vaccine-preventable diseases. The ACPE Standards 2016 has now explicitly listed under the public-health
domain that “[providing] an avenue through which students
become certified in immunization delivery”21 is a required
element of any Pharm D curriculum. In addition to a curriculum that produces pharmacists capable of identifying and
solving public-health issues, the Pharm D graduate’s training
and expertise lies with pharmaceuticals. Since vaccines and
biological products are approved by the US Food and Drug
Administration and considered prescription (pharmaceutical)
products, pharmacists are uniquely qualified to not only serve
as drug experts but also vaccine experts as well.
Pharmacy-based immunization training for pharmacists
also follows a nationally adopted certificate training program developed by the American Pharmacists Association
(APhA), and the quality and content of this program in
preparing pharmacists to administer vaccines are recognized
by the CDC’s National Immunization Program.22 The APhA
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Pharmacy-Based Immunization Delivery program involves
three components: 1) a 12-hour self-study that covers immunology, vaccines, patient care, practice implementation, and
legal and regulatory issues; 2) a live 8-hour program that
reinforces and expands on the self-study content and focuses
on immunization decision-making and pharmacy-practice
implementation; and 3) a practicum that assesses subcutaneous and intramuscular injection techniques.23 This program
has trained more than 150,000, and counting, pharmacists
and student pharmacists nationwide.22,24
With the public’s increased ability to access pharmacists,
pharmacists are perfectly positioned and have notable training to engage in conversations with patients to prompt vaccine reminders and recommendations, and dispel myths and
misconceptions regarding vaccinations.25 In addition to this,
pharmacists have consistently ranked as one of the top three
most honest and ethical professions in the USA.26

Journey to pharmacist-provided
vaccinations in the USA
Although community pharmacies and pharmacists are
recognized today by the CDC and the US Food and Drug
Administration as established nontraditional settings and
providers, most of this achievement took place just within
the last two decades. Pharmacy involvement with vaccines
and immunization in the USA has been noted since the
mid-1800s but was limited in function, with pharmacies
serving as a source of storage, preparation, distribution,
and education, and as hosts of immunization providers
in their practice.22,27 In 1993, then-secretary of the US
Department of Health and Human Services (DHHS)
Donna Shalala requested the APhA to define the role of
pharmacists in improving vaccination rates. The APhA’s
response was successful in getting the DHHS to officially
recognize that pharmacists are able to play an integral role
in vaccine education, mobilization, distribution, access,
record keeping, administration, and, ultimately, improving
vaccination rates.22 From this, the first organized immunization training program for pharmacist-administered immunizations took place in Seattle, Washington, in late 1994.
Pharmacists’ movement into adult immunization came in
1996 and resulted from collaboration between the Mississippi Pharmacists Association and the APhA to address
the Mississippi Department of Public Health’s request for
pharmacists in resolving the disparities in adult influenza
and pneumococcal rates. This effort lead to the development
of the now nationally recognized APhA Pharmacy-Based
Immunization Delivery certificate program.22
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Turf wars with physicians continue to be a challenge as
pharmacists look to expand the ages of patients they can
vaccinate, the types of vaccines they can administer, and
their responsibilities by becoming independent providers of
immunizations. The American College of Physicians supports
pharmacists as a source of immunization information, facilitators of immunizations, and as immunizers, as appropriate
and allowed by state law.28 In March of 2014, the National
Vaccine Advisory Committee published its recommendations
for adult immunization standards.29 These recommendations
call for all providers, including pharmacists, to implement
policies and processes that increase adult vaccination. Most
mainstream medical and allied health care provider organizations have signed on to promote this document. While there
has been widespread support of pharmacy-based immunization programs under collaborative practice agreements,
physician resistance and attitudes tend to be less favorable
when community pharmacists take on an independent role
in patient care.30,31 These opinions may vary among states,
as an example of support was the California Association of
Physician Groups helping California pharmacists achieve
provider status and independent immunization practice in
2013 under Senate Bill 493.32,33

State-based pharmacist
immunization laws
In the USA, all health care is delivered based not on
federal but state law. Currently, all 50 states in the USA,
and Washington DC and Puerto Rico, allow pharmacists
to administer vaccinations. However, among states, laws
vary for the need for a protocol and/or prescription to give
a vaccine, minimum age limit, and the vaccines pharmacists are authorized to administer. The latest APhA and
National Alliance of State Pharmacy Associations’ survey
of state immunization laws/rules, report that 31 states
require pharmacist-administered vaccines to be pursuant
to a protocol or prescription, while 12 allow for a protocol,
prescription, or no prescriber needed (depending on the age
and/or vaccine).34 The remaining states and US territories
allow pharmacists to administer vaccines via protocol only
or prescription only. Regarding age and types of vaccines,
27 states do not have a patient age limitation for pharmacistadministered vaccines, and 46 states currently authorize
pharmacists to administer any type of vaccine. Patient age
limitations in states range from those 5 years of age or older
to those greater than 18 years of age. State laws also vary in
the authority for student pharmacists to administer vaccines
(eight states do not allow student pharmacists to vaccinate).
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The State of California was the most recent state to move
from a 1995 law that allowed pharmacists to “administer
immunizations pursuant to a protocol with a prescriber” to
independent initiation of vaccines for those 3 years of age
and older.35 Information on current state laws pertaining to
pharmacist authority to immunize is updated regularly on
the APhA’s Immunization Center webpage (http://www.
pharmacist.com/immunization-center).

Role of the pharmacist
in immunizations
In 1997, the APhA published a set of guidelines for pharmacybased immunization advocacy that can still be applied today
to the role of community pharmacists in immunizations.36
The organization encourages all pharmacists to adopt a
level of involvement in vaccinations as either an educator
(encouraging immunizations to patients served), facilitator
(serving as a depot for vaccine distribution or host for immunizers), or immunizer (administering vaccinations consistent
with state law).36 Today, community pharmacists still serve in
vaccine advocacy roles within their practice setting.
Although this review focuses on the role of community
pharmacists in providing vaccinations, it is worth noting that
pharmacists also play an important role in immunizations
in the inpatient and health-systems setting. In this setting,
pharmacists primarily serve as educators and facilitators to
increase immunization rates. As part of the health care team,
pharmacists provide immunization screening and recommendations for at-risk patients, carry out standing orders
with nursing staff, and develop protocols and collaborative
agreements with physicians.22,37–39 Guidelines on the pharmacists’ role in immunization in the inpatient or health-systems
setting have been published by the American Society of
Health-System Pharmacists (http://www.ashp.org/s_ashp/
docs/files/BP07/Specific_Gdl_Immun.pdf [accessed May 14,
2015]).40
The remainder of this review highlights the roles
and contributions of community pharmacists as vaccine
providers through the roles of educators, facilitators, and
immunizers.

Pharmacists as vaccine educators
Community pharmacists are valuable sources of information for patients. As vaccine educators, pharmacists act to
educate and recommend to the patients the importance of
and need for receiving vaccinations. Physician views toward
the community pharmacist’s role in patient advocacy include
assisting physicians in monitoring pharmacotherapy, and
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providing patient counseling and medical information.30,41
The coordination and education regarding the importance
of receiving routine and recommended vaccinations, and
the vaccine product itself, would fall into this view of community pharmacists as sources of information. As discussed
earlier, pharmacists have been trained in providing clinical
services and patient communication; it is only appropriate
that they employ this training in advocating vaccinations.
Pharmacist-provided patient vaccine education, screening,
and recommendations have been shown to increase vaccination rates.42
Pharmacists have been successful in their role as vaccine educators by screening patients and providing recommendations to patients and providers. As providers of
medication therapy management and a source of patient
medication records, community pharmacists are able to
identify patients at risk for vaccine-preventable diseases
through use of pharmacy data and patient interviews.43,44
In an interview of seniors taking three or more medications concurrently according to pharmacy records, the most
common pharmacist-identified drug-related problems were
“patient required drug therapy” or “patient requires influenza
or pneumococcal vaccination”.43 Pharmacists are able to
review prescription records to create “inferred diagnosis”
when the medical record is not available, and identify the
need for a specific vaccination. For example, screenings for
the pneumococcal vaccine can target those 65 years of age
or older, those with immunocompromising medications,
those with respiratory or diabetes medications; or the Tdap
(tetanus, diphtheria, and pertussis) vaccine for females with
prenatal prescriptions or picking up infant-care supplies. This
information can be obtained from the patient’s pharmacy
profile and prescription history in the pharmacy information management system (PIMS). The screening for and
recommending of vaccinations are part of the pharmacist’s
responsibility in monitoring drug therapy, and includes identification of lack of therapy and preventative measures such
as routine and recommended vaccinations.
Community pharmacists also educate the community
through awareness campaigns and distributing literature
on the need for vaccination and where to obtain the needed
vaccinations. Using a combination of screening pharmacy
records, distributing vaccine literature, and urging vaccination, community pharmacists in the Isle of Wight, England,
vaccinated 9.7% of all patients who received influenza vaccine on the island during the 2010–2011 influenza season.
They also noted that it was a pharmacy staff reminder that
led to the initiation of two-thirds of these vaccinations.45
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Similar results exist for pharmacist-driven interventions for
the zoster vaccine. Pharmacists and pharmacy staff who promoted the zoster vaccine and provided personal selling and
patient education were able to increase the number of zoster
vaccinations compared with when there was no pharmacist
intervention.46–49 With a lack of physician recommendation to
patients and patients’ misassumption of their perceived need
for vaccinations, pharmacists can recapture these patients and
engage them in conversation about needed vaccinations.50
The pharmacist’s role as a vaccine educator enhances patient
adherence to vaccinations through initiating an open discussion, providing education, and patient follow-up with the
pharmacist. These techniques are similar to those employed
in the pharmacist’s role in improving patient adherence to
other medications.51

Pharmacists as vaccine facilitators
As discussed earlier, early pharmacist involvement with
immunizations was limited to the distribution of vaccine
products and hosting of immunization providers in their
pharmacy. Community pharmacists facilitated immunizations given by other health care providers, such as physicians and nurses, by providing their pharmacies as venues
to provide vaccines. Hosting other providers was usually
limited to 2–3 days during the fall and for a short number
of hours during each event. Revenue generated from such
events was also retained by the providers of immunization,
and the pharmacy benefited through goodwill and collateral
sales.52 However, with all states currently allowing pharmacists to immunize, modern community pharmacists now use
their pharmacies to host their own immunization services
year-round. This movement away from being distributors
or facilitators to being full providers of immunizations may
explain the scarce literature on the role of pharmacists as
vaccine facilitators and distributors.
As vaccine distributors, pharmacies facilitate other providers in administering vaccinations by ordering and distributing vaccine products to physicians and medical clinics. In
a random sample of community pharmacies from 17 states,
about one in five pharmacies engaged in vaccine distribution
by reselling or distributing vaccines to local physicians and/
or clinics.53 Common vaccines that were distributed to other
providers for administration were the hepatitis A, hepatitis
B, meningococcal, MMR (measles–mumps–rubella), and
tetanus-containing vaccines.54 Although this is a minor role
for pharmacy, it should be continued. A survey of family
practitioners and general internists revealed that many primary care providers (PCPs) do not stock all recommended
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adult vaccines, with only 12% planning to increase their
offerings and 2% planning to stop altogether.55 With barriers
in reimbursements for pharmacy-administered vaccinations,
some patients insist on receiving vaccinations from their
PCP because it is covered under their medical benefits. In
this case, PCPs will need access to vaccines they do not
normally stock.
The pharmacist’s role as a facilitator improves immunization rates by increasing other health care providers’
accessibility to vaccine products and the locations where
these providers can offer immunization services. In this role,
pharmacists also aid other providers in improving their immunization offerings and rates of immunizations. It is important
to note that while community pharmacists no longer serve
in the originally defined role of facilitators (hosting other
providers of immunizations), serving as facilitators was
important in the progression of community pharmacists
to immunizers by presenting the public with the concept
of vaccination delivery in the pharmacy setting. For countries looking to implement pharmacy-based immunization
delivery services, we suggest pharmacies serve as vaccine
facilitators to trial immunization services in the pharmacy
and expose the public and health system to vaccine delivery
occurring in the community pharmacy.

Pharmacists as immunizers
According to the APhA Annual Pharmacy-Based Influenza and Adult Immunization Survey 2013, pharmacists
provide vaccinations in 86% of community pharmacy
settings. Patients are also increasingly being referred to
the pharmacy from their PCP for immunizations by the
pharmacists.56 With pharmacists authorized to administer
vaccines in all 50 states, the most effective and efficient
pharmacist role for providing vaccination services is to
serve as an immunizer. As active immunizers, pharmacists
assess patients for indications and contraindications and
administer vaccines directly to the patients that they serve.
Immunizing pharmacists follow the recommendations and
immunization schedules provided by the Advisory Committee on Immunization Practices and the CDC. In a review of
interventions to increase influenza and pneumococcal vaccination rates among community-dwelling adults, results
showed that pharmacist interventions were ineffective when
pharmacists only gave reminders to physicians and did not
themselves administer the vaccinations.57 This role as an
immunizer offers pharmacists the ability to deliver complete and successful immunization services by combining
the roles of vaccine educator and immunizer.
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The literature is abundant with data supporting the role
and impact of community pharmacists as immunizers.
Community pharmacy-based immunization services are a
cost-effective, convenient, and accessible alternative for the
public to receive vaccinations.10,15 As stated earlier, one of
the greatest barriers to vaccinations is accessibility. With
pharmacists as immunizers, pharmacists are able to immediately act on their recommendations (administer the patient
the vaccine) without referring the patient elsewhere, where
the patient may not follow through or forget. With increased
accessibility, pharmacists have helped to improve immunization rates, bring patients up-to-date on vaccinations, and
reach those who may not otherwise have an opportunity to
be vaccinated.11,18,45,58–60 When comparing patients 50 years
or older who obtained their medications from a community
pharmacy to those that did not, community pharmacy patients
had a higher rate of receiving the influenza immunization.61
Prior to all states allowing pharmacists to provide vaccinations, states that allowed pharmacists to vaccinate were
associated with higher influenza vaccination rates for those
65 years and older.62 In emergency-response situations
requiring mass vaccinations, pharmacist immunizers, with
a higher patient-to-practitioner ratio, have also been able to
reach a larger portion of the community than other types of
vaccine providers.63

Practice model
An outsourced or in-house approach can be taken to implementing immunization services inside the community
pharmacy.64 In the outsourced model, pharmacies may
contract with other professionals, notably nurses, to provide
immunization services within the pharmacy during certain
months, for example, influenza season and back to school
months. The outsourced approach is essentially pharmacies participating in the vaccine facilitator role. Using an
outsourced mechanism does not require much commitment
from the hosting pharmacy beyond providing space in the
pharmacy for the contracted immunization provider to work.
Outsourced immunization services also require minimal
pharmacy staff participation, allow for the trial of immunization services within the pharmacy, and are less likely to
disrupt dispensing activities.64 This model is no longer used
in US community pharmacies, since most pharmacies have
an immunization-trained pharmacist on staff to carry out the
vaccine-administration services within their own pharmacy.
Community pharmacies tend to utilize their immunizationtrained staff pharmacists to deliver all aspects of the immunization service alongside their distribution services. This is the
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second approach to implement pharmacy-based immunization
services and is known as an in-house vaccination service. Of
the two mechanisms to deliver pharmacy-based immunization services, the in-house vaccination service offers the most
effective and constructive outcome to public health and the
pharmacy profession. As stated before, in-house services,
where pharmacists are immunizers, improve vaccination
rates and increase access/convenience for patients.44,45,59,61
In-house pharmacy immunization services have also been
shown to be more cost-effective compared with physician
office vaccinations.10 Unlike the outsourced method, in-house
services are able to provide a wider range of vaccines yearround in the pharmacy and allow the pharmacy to retain the
revenue generated from the immunization services.52 These
in-house services improve the pharmacy business by bringing
in revenue; patient care, by increasing vaccine and vaccineprovider access for patients; and the pharmacy role/profession, by expanding the role of clinical pharmacy services.65
Some published guides are available to assist pharmacists in
developing and implementing clinical pharmacy services in
the community setting.66,67
Pharmacist-provided immunizations typically require
a protocol with a physician, similar to the standing orders
that nurses, nurse practitioners, and physician assistants
may operate under.24 Depending on the specific state’s laws
and regulations, pharmacists may initiate and administer
vaccines under a collaborative practice agreement, protocol, or prescription order. The source and authorization
of pharmacists provided with immunization protocols or
standing orders are driven by the individual state’s laws and
regulations. In general, protocols allow one physician to
sign for multiple pharmacists and all patients who present
to the pharmacy. While the protocol is currently the most
common authorization for pharmacists to immunize, it can
also serve to limit immunization access. Protocols cannot
be more liberal than a state law, but they can be stricter. For
example, physicians or organizations may, for example, raise
the age limit; prohibit the vaccination of pregnant women;
or require a prescription for pediatric vaccines, even though
state law does not require it. Lastly, it may be difficult for
independent pharmacists to find a physician to sign their protocol because the physician may perceive there to be greater
liability than there really is or lack of a financial incentive.
Chain pharmacies often either employ their protocol physician or are able to provide enhanced liability protection and
financial incentives to a protocol physician.
The delivery and workflow of an in-house community
pharmacy immunization service varies from pharmacy
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to pharmacy. Immunization services can be provided by
appointment, on a walk-in basis, or a combination of both.
The Annual Pharmacy-Based Influenza and Adult Immunization Survey 2013 reported that a majority of pharmacy
practice sites offer vaccinations on a walk-in basis, with an
increasing trend for pharmacies to adopt the walk-in service.56
Appointment-based services tend to be less disruptive to the
pharmacy’s normal workflow, as patient volume is planned
and expected, however it can limit the number of patients
who can be vaccinated. Walk-in-based services are more
convenient for patients but may cause disturbances to the
normal pharmacy workflow to accommodate the patients.
Walk-in services might also mean that the pharmacy has
to stock a wide range of, if not all, vaccines at all times
because the requested vaccine and patient screening cannot
be determined in advance. The time it takes to provide the
comprehensive vaccination service can vary depending on
the number of pharmacists or student pharmacists available;
pharmacy dispensing volume; insurance billing versus paying
out-of-pocket; and patient screening, counseling, and education needs. The actual time it takes to administer the vaccine
may only take 5 minutes or less.68
Other essential workflow and physical pharmacy environment needs for an in-house immunization service are a private
patient-care area, adequate vaccine storage equipment, and
emergency-response preparedness. While most pharmacies
have been designed without private patient exam rooms,
offering an immunization service only requires a semiprivate
patient-care area. Pharmacies offering immunizations and
patient-care services have met this need by repurposing existing space, or some have required remodeling of the physical
pharmacy floor plans. A pharmacy providing vaccination
services is also required to have adequate refrigeration and
freezer equipment to ensure the potency and safe storage of
vaccine products. Pharmacists who provide immunizations
should also be adequately prepared for the management of
adverse reactions that may occur. These may range from
injection-site reactions and syncope to more severe reactions
such as anaphylaxis. In addition to clear written protocols on
the management of these reactions, immunizing pharmacists
should be trained in cardiopulmonary resuscitation and have
emergency supplies that consist of epinephrine, diphenhydramine, a blood pressure cuff, and a stethoscope. Upon
completion of the injection, patients are asked to remain
seated in the pharmacy for observation for approximately
15 minutes for any immediate syncopal or anaphylactic
reactions. The CDC has published general recommendations
regarding communicating risk and benefits, administration
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and storage, management of adverse events, special populations, record keeping, and resources for clinicians involved in
the delivery of immunization services.69 The National Vaccine
Advisory Committee has also provided recommendations
for the standards of adult immunization practices to improve
immunization practice and policy development.70,71

Current challenges
Despite the successes, community pharmacy-based vaccination services still face some challenges. Barriers noted
include variability in laws at the state level regarding pharmacists’ administration of vaccines, inconsistent reimbursement
and compensation systems, and barriers to accessing health
information technology. Although pharmacists in all 50 states
and US territories are authorized to administer vaccines,
the process (allowed under protocol, standing order, and/or
prescription), patient age, and type of vaccine permitted vary
considerably. These scopes of practice are determined individually at the state level, and the variability and limitations
of some state regulations restrain the ability of pharmacists
to fully contribute to immunization public-health efforts.
The lack of recognition by all states that pharmacists are
appropriately trained and professionally competent providers of immunizations who are able to increase the rate of
vaccinations and improve public health may explain why
some states still place limits on pharmacist immunization
authorities. Individual states, with their pharmacists and local
pharmacy associations, should continue to work with their
state pharmacy boards and other stakeholders to advance their
immunization scope of practice. This lack of wide recognition
is also said to be the reason why inconsistent reimbursement
designs for pharmacy-provided immunizations exist.25
For community pharmacy-based vaccination services,
a limited number of commercial and governmental health
plans offer patients coverage for receiving vaccinations
from a pharmacy, and, even when provided, they do not
always cover all recommended vaccines.72 For example,
Medicare covers the pneumococcal and influenza vaccine
in the pharmacy under the Part B medical benefits, but the
shingles vaccine is covered under the Part D prescription
benefits. This may also be a barrier for patients looking to
receive a set of vaccinations from their PCP, who cannot bill
under prescription drug benefits. Generally, for commercial
health plans, if a vaccine is not covered under the pharmacy
benefits, it is covered under the patient’s medical benefits,
which the pharmacy may have difficulty billing. Limited or
restricted benefits for pharmacy-provided immunizations
mean that the patient either has to go elsewhere or pay high
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out-of-pocket fees. This may result in the patient skipping the
vaccine altogether or deferring vaccination. This is further
complicated by the fact that most patients like the convenience of going to a pharmacy versus making an appointment
with their PCP, and that many may seek vaccinations after
normal physician office hours.18 Immunization services carry
a cost for the vaccine product itself and for the cost of the
administration. For physicians and for pharmacists, many
times, the reimbursements barely cover the cost of the vaccine product and administration, resulting in no net revenue
or even a loss.73,74 Immunization stakeholders believe that if
all CDC-recommended vaccines can be billed from either
the pharmacy or medical benefit (with uniformity in cost
sharing and reimbursement for product and administration
cost across all provider types), it will decrease the barriers
to patient access to immunizations and incentivize pharmacies (and other immunizers) to increase their immunization
offerings and efforts.24 As medical care efforts increasingly
focus on preventative measures in accordance with the
Affordable Care Act (2010), there are increased incentives
for benefit designs to include pharmacy-based vaccination
benefits.72 Pharmacists are also encouraged to work with
private employers/employer plans to seek further avenues for
reimbursements and reaching more of the public.
There are also barriers in technology that exist in this setting; from a lack of shared patient record systems to inadequate
PIMSs that provide patient-specific immunization notifications
and scheduling of patients. Currently, only about 63% of
pharmacy immunization sites surveyed provide documentation
of patients’ immunization directly to the PCP, and only 35%
report to an immunization registry (with another 11% stating
pharmacists are not permitted access to their state or local
immunization registries).56 A lack of patient record systems
shared with the patient centered medical home (PCMH), the
PCP charged with coordinating care, has led to inconsistent
communication between pharmacists and PCPs regarding
patients’ current immunization status and records. Also,
variability exists in state-level laws regarding mandates for
pharmacists and other immunization providers to report to the
state’s immunization information system (IIS) or immunization
registries.75 The IIS gathers data on patients’ immunization
records from a variety of immunization providers in the hope of
compiling a complete record for continuity of care and public
health. Immunization registries in which not all providers and
all vaccines are mandated to be entered provide an incomplete
record of an individual’s immunization status, possibly leading
to under- or over-vaccination. Some challenges conveyed for
pharmacy IIS reporting are that many PIMSs cannot directly

74

submit your manuscript | www.dovepress.com

Dovepress

communicate with the IIS; time-consuming paperwork and
disruption of workflow; and lack of standard reporting mandates, procedures, and formats.76 Some health information
technology companies have been working on solutions to
overcome some of these issues, however, “the capabilities
for pharmacies to interface with [IIS] at this level are still
in the early stages”.75 Another limitation in technology that
may create some challenges for community pharmacy-based
immunization services is that PIMSs used by pharmacies are
generally not equipped with patient scheduling and patient
recommendation features based on the patient’s records.
These features assist in patient follow-up and scheduling of
vaccines that consist of multiple-dose series; they also help
assist the pharmacist in prompting recommendations to the
patients after the technology has queried the patient’s records
for indications that may correlate with age, medications, and/
or diagnoses. These electronic clinical reminders are typically
seen in electronic medical records and not in a PIMS.

Future considerations
Looking into the future, there are actions that can be taken
to ensure the continual success and expansion of community
pharmacy-based vaccination services. To do this, we should
focus future efforts on education, national legislative changes,
reimbursement design, integration of immunization workflow
into a PIMS, and communication with the PCMH. As health
care needs and public-health initiatives grow and change, the
training and education of student and current pharmacists
must also be revised to meet these changes effectively. An
increased emphasis on the role of pharmacists in public health
will help pharmacists increase their credibility, expand their
scope of practice at the micro- and macro-levels of public
health, and hopefully provide pharmacist recognition and
legislative changes at a national level as providers that are
part of the PCMH.77–79 Ways to achieve this may be to incorporate public-health courses and public-health experiential
education opportunities into the Pharm D curriculum, offer
joint Pharm D and Master of Public Health (MPH) degree
programs, increase continuing education topics in public
health, and have pharmacists and pharmacy stakeholders
participate in legislative actions. It has been suggested that
pharmacists functioning as vaccine educators and immunizers could increase educational campaigns focusing on
disparities and aimed at bridging the gap among racial and
ethnic populations.61 Pharmacists can also expand beyond the
community pharmacy to other community settings (churches,
malls, senior centers, colleges, workplaces, etc) and have these
locations host an immunizing pharmacist.
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Legislative and regulatory changes that will benefit the
future sustainability of community pharmacy-based vaccination
are standardized recognition for pharmacists to furnish all
CDC-recommended vaccines to indicated patients as well as
uniform provider recognition among benefit plans for improved
reimbursement and compensation. Other avenues for increasing
performance may be to implement vaccine-related performance
measures or incentives in immunizing pharmacists’ payer
contracts. Although no states permit pharmacy technicians to
administer vaccines, the pharmacy technician can serve a role
in the pharmacy’s immunization services. Pharmacy technicians can be delegated with tasks related to inventory, patient
scheduling, and intake; prescription processing and payment;
and administrative work. Engaging the pharmacy technician can
minimize the time pharmacists spend on these areas and cause
less disruption in the pharmacist’s normal workflow. Another
advancement that can assist in improving the pharmacists’
efforts and save time is the use of PIMS software that can provide electronic clinical alerts for patient immunization needs,
send reports to the state IIS, and communicate with PCPs.

Conclusion
With the appropriate training/education, accessibility, and
effective provision of immunizations in community pharmacies, pharmacists are uniquely positioned to improve
immunization rates and public-health efforts. Serving as
immunization advocates in the roles of educators, facilitators,
and immunizers, community pharmacists motivate patients to
receive immunizations, enable other providers to immunize,
and directly vaccinate the patients that they serve. Although
much success has been seen in the past few decades, as evidenced by all pharmacists now being authorized to immunize,
barriers such as variable scope of immunization practice
for pharmacists across states, inconsistent reimbursement
mechanisms, and barriers in technology still exist in this
setting. Continued and future success in this area requires
calls for action from educators, legislators, payers, and the
health information technology community.
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